GATA1 is overexpressed in patients with essential thrombocythemia and polycythemia vera but not in patients with primary myelofibrosis or chronic myelogenous leukemia

Leukemia and Lymphoma

Volumn 49, Issue 7, 2008, Pages 1416-1419

  Rinaldi, Ciro R ^a   Martinelli, Vincenzo ^a   Rinaldi, Paola ^a   Ciancia, Rosanna ^a   del Vecchio, Luigi ^a   Pane, Fabrizio ^a   Nucifora, Giuseppina ^b   Rotoli, Bruno ^a  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^b UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; COMPLEMENTARY DNA; JANUS KINASE 2; TRANSCRIPTION FACTOR GATA 1;

ADULT; AGED; ARTICLE; BONE MARROW BIOPSY; CHRONIC MYELOID LEUKEMIA; CONTROLLED STUDY; DISEASE MARKER; ERYTHROCYTOSIS; FEMALE; GENE EXPRESSION; GENE MUTATION; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; IDIOPATHIC THROMBOCYTOPENIC PURPURA; MAJOR CLINICAL STUDY; MALE; MUTATIONAL ANALYSIS; MYELOID METAPLASIA; PATHOGENESIS; POLYCYTHEMIA VERA; PRIORITY JOURNAL; THROMBOCYTHEMIA; THROMBOCYTOSIS;

ADULT; AGED; FEMALE; GATA1 TRANSCRIPTION FACTOR; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; JANUS KINASE 2; LEUKEMIA, MYELOGENOUS, CHRONIC, BCR-ABL POSITIVE; MALE; MIDDLE AGED; MYELOFIBROSIS; POLYCYTHEMIA VERA; THROMBOCYTHEMIA, HEMORRHAGIC; UP-REGULATION;

EID: 47649118834     PISSN: 10428194     EISSN: 10292403     Source Type: Journal    
DOI: 10.1080/10428190802087462     Document Type: Article

References (17)

1. Lowry, J. A. and Mackay, J. P. (2006) GATA-1: One protein, many partners. Int J Biochem Cell Biol, 38, pp. 6-11.
2. Mehaffey, M. G., Newton, A. L., Gandhi, M. J., Crossley, M. and Drachman, J. G. (2001) X-linked thrombocytopenia caused by a novel mutation of GATA-1. Blood, 98, pp. 2681-2688.
3. Del Vecchio, G C, Giordani, L., De Santis, A. and De Mattia, D. (2005) Dyserythropoietic anemia and thrombocytopenia due to a novel mutation in GATA-1. Acta Haematol, 114, pp. 113-116.
4. Greene, M. E., Mundschau, G., Wechsler, J., McDevitt, M., Gamis, A. Karp, J. et al. (2003) Mutations in GATA1 in both transient myeloproliferative disorder and acute megakaryoblastic leukemia of Down syndrome. Blood Cells Mol Dis, 31, pp. 351-356.
5. Crispino, J. D. (2005) GATA1 mutations in Down syndrome: Implications for biology and diagnosis of children with transient myeloproliferative disorder and acute megakaryoblastic leukemia. Pediatr Blood Cancer, 44, pp. 40-44.
6. Yamaguchi, Y., Zon, L. I., Ackerman, S. J., Yamamoto, M. and Suda, T. (1998) Forced GATA-1 expression in the murine myeloid cell line M1: induction of c-Mpl expression and megakaryocytic/erythroid differentiation. Blood, 91, pp. 450-457.
7. Iwasaki, H., Mizuno, S., Wells, R. A., Cantor, A. B., Watanabe, S. and Akashi, K. (2003) GATA-1 converts lymphoid and myelomonocytic progenitors into the megakaryocyte/erythrocyte lineages. Immunity, 19, pp. 451-462.
8. Vannucchi, A. M., Bianchi, L., Paoletti, F., Di Giacomo, V, Migliaccio, G. and Migliaccio, A. R. (2004) Impaired GATA-1 expression and myelofibrosis in an animal model. Pathol Biol (Paris), 52, pp. 275-279.
9. Vannucchi, A. M., Pancrazzi, A., Guglielmelli, P., Di Lollo, S, Bogani, C. Baroni, G. et al. (2005) Abnormalities of GATA-1 in megakaryocytes from patients with idiopathic myelofibrosis. Am J Pathol, 167, pp. 849-858.
10. Wolanskyj, A. P., Lasho, T. L., Schwager, S. M., McClure, R. F., Wadleigh, M. Lee, S. J. et al. (2005) JAK2 mutation in essential thrombocythaemia: Clinical associations and long-term prognostic relevance. Br J Haematol, 131, pp. 208-213.
11. Tefferi, A., Lasho, T. L. and Gilliland, G. (2005) JAK2 mutations in myeloproliferative disorders. N Engl J Med, 353, pp. 1416-1417.
12. Levine, R. L., Wadleigh, M., Cools, J., Ebert, B. L., Wernig, G. Huntly, B. J. et al. (2005) Activating mutation in the tyrosine kinase JAK2 in polycythemia vera, essential thrombocythemia, and myeloid metaplasia with myelofibrosis. Cancer Cell, 7, pp. 387-397.
13. Tefferi, A., Lasho, T. L., Schwager, S. M., Steensma, D. P., Mesa, R. A. Li, C. Y. et al. (2005) The JAK2(V617F) tyrosine kinase mutation in myelofibrosis with myeloid metaplasia: Lineage specificity and clinical correlates. Br J Haematol, 131, pp. 320-328.
14. Tefferi, A. and Vardiman, J. W. (2008) Classification and diagnosis of myeloproliferative neoplasms: The 2008 World Health Organization criteria and point-of-care diagnostic algorithms. Leukemia, 22, pp. 14-22.
15. Baxter, E. J., Scott, L. M., Campbell, P. J., East, C., Fourouclas, N. Swanton, S. et al. (2005) Acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disorders. Lancet, 365, pp. 1054-1061.
16. Patmasiriwat, P., Fraizer, G., Kantarjian, H. and Saunders, G. F. (1999) WT1 and GATA1 expression in myelodysplastic syndrome and acute leukemia. Leukemia, 13, pp. 891-900.
17. Debili, N., Coulombel, L., Croisille, L., Katz, A., Guichard, J. Breton-Gorius, J. et al. (1996) Characterization of a bipotent erythro-megakaryocytic progenitor in human bone marrow. Blood, 88, pp. 1284-1296.